Recombinant protein vaccines, like the Novavax vaccine used to fight COVID-19, offer several advantages over conventional vaccines. They’re easy to
Day: February 28, 2024
A new, comprehensive roadmap for the future of biomedical engineering
The field of biomedical engineering anticipates an amazing future for the field, its researchers, and students. IEEE, the world’s largest
Long-term data reveals SARS-CoV-2 infection and vaccine-induced antibody responses are long-lasting
A long-term analysis conducted by leading microbiologists at the Icahn School of Medicine at Mount Sinai reveals that antibody responses
Maths: Smart learning software helps children during lockdowns — and beyond
Intelligent tutoring systems for math problems helped pupils remain or even increase their performance during the Corona pandemic. This is
Addressing societal concerns of genetic determinism of human behavior by linking environmental influences and genetic research
It has long been known that there is a complex interplay between genetic factors and environmental influences in shaping behavior.
New disease testing component facilitates lower-cost diagnostics
A new tool could reduce costs for diagnosing infectious diseases. Biomedical researchers from The University of Texas at Austin have
Revealing what makes bacteria life-threatening
Queensland researchers have discovered that a mutation allows some E. coli bacteria to cause severe disease in people while other
Fecal microbiota transplant recommended for the majority of recurrent C. diff patients
In the first comprehensive evidence-based guideline on the use of fecal microbiota-based therapies for gastrointestinal disease, the American Gastroenterological Association
Researchers use deep brain stimulation to map therapeutic targets for four brain disorders
A new study led by investigators from Mass General Brigham demonstrated the use of deep brain stimulation (DBS) to map
Artificial intelligence matches or outperforms human specialists in retina and glaucoma management
A large language model (LLM) artificial intelligence (AI) system can match, or in some cases outperform, human ophthalmologists in the